Alterity Therapeutics Income Statement (2015-2025) | ATHE

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Operating items
Research & Development (Quarter)
0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B
Share-based Compensation (IS) (Quarter)
0.00B0.00B0.00B0.00B0.00B
Selling, General & Administrative (Quarter)
0.00B-0.00B-0.00B-0.00B0.00B-0.00B
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
0.00B-0.00B-0.01B-0.01B0.00B0.00B0.01B-0.00B0.00B
EBIT (Quarter)
-0.00B-0.00B-0.00B-0.00B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B
Other Non Operating Income (Quarter)
-0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B
Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-0.00B-0.00B-0.00B-0.00B
Profit After Tax (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B
Income from Non-Controlling Interests (Quarter)
-0.00B-0.00B-0.00B-0.00B
Income from Continuing Operations (Quarter)
-0.00B-0.00B-0.00B-0.00B
Consolidated Net Income (Quarter)
-0.00B-0.00B-0.00B-0.00B
Income towards Parent Company (Quarter)
-0.00B-0.00B-0.00B-0.00B
Net Income towards Common Stockholders (Quarter)
-0.00B-0.00B-0.00B-0.00B
Additional items
EPS (Basic) (Quarter)
-2.52-5.32-3.45-8.68
EPS (Weighted Average and Diluted) (Quarter)
-2.52-2.57-3.45-8.68
Shares Outstanding (Weighted Average) (Quarter)
0.00B0.00B0.40B0.00B0.40B0.00B0.60B0.00B0.68B142,454.29B1.60B155,764.22B0.15B140,488.96B2.14B139,947.63B3.46B146,172.09B168,401.57B185,491.37B
Shares Outstanding (Diluted Average) (Quarter)
0.00B0.00B0.00B0.00B0.59B1.31B1.72B1.62B2.40B4.10B
EBITDA (Quarter)
-0.00B-0.00B-0.00B-0.00B